Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Europe Approves JHL Biotech's Clinical Trial Application for Bevacizumab Biosimilar to Affordably Treat Colorectal, Lung, and Ovarian Cancers 2018-02-22 21:00
AMRI to Expand Container Closure Integrity Testing Services (CCIT) into European Union 2018-02-22 20:00
Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia 2018-02-21 09:00
Frost & Sullivan Recognizes 3M as a Product Leader in the Biologics Downstream Manufacturing Arena 2018-02-20 22:00
PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates 2018-02-14 21:30
China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results 2018-02-14 21:00
Cedrus Investments' Chairman Mr. Rani Jarkas is Invited to Speak at the Hong Kong Biotech Invest and Partnering 2018 2018-02-13 16:00
Ondine Biomedical Inc. Announces the Appointment of Joseph Sowell, III to Board of Directors 2018-02-13 07:52
Saama Technologies Earns Frost & Sullivan's Recognition as a Technology Leader, with its Real-World Evidence IT Solutions 2018-02-12 21:00
JHL Biotech's Final Trading Day on Taipei Exchange 2018-02-12 08:00
Ondine Biomedical, Inc. Announces the Appointment of Vicente Fox, Former President of Mexico (2000 - 2006) to Board of Directors 2018-02-09 10:42
China Cord Blood Corporation to Change Corporate Name to "Global Cord Blood Corporation" 2018-02-07 20:00
Golden Meditech Announces FDA Registration of GMP Manufacturing Facility by its Associate, Cellenkos, Inc. 2018-02-07 17:31
Frost & Sullivan Publishes Update Coverage Report on DNA Biomedical Solutions Ltd.: Entera's unsuccessful NASDAQ IPO is not expected to have a significant impact on its clinical plans; Price target affected by a change in the exchange rate. 2018-02-06 18:07
Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial 2018-02-06 07:00
JHL Biotech's Application to Voluntarily Terminate Trading of Shares Approved by Taipei Exchange 2018-02-05 08:53
JHL Biotech Shareholders Vote to Voluntarily Delist from Taiwan Exchange 2018-02-01 22:00
Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation 2018-01-31 21:00
Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence 2018-01-31 19:00
Global Digital Pathology Market Set to Witness Double-Digit Growth 2018-01-24 19:38
1 198 199 200 201 202 224